Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and sub and superpotent.
Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and sub and superpotent.
We break every recall down into plain English — this one’s still on our list. Until our write-up is ready, the official FDA hazard and remedy below have the full, accurate details.
We’ve drafted a message you can send GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline to request your refund or repair — edit it as you like.
Subject: Recall D-1247-2014 — GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline GlaxoSmithKline Consumer Healthcare; dba-G Hello, I own a GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline recalls Nicorette Lozenge and NicoDerm CQ, nicotine polacrilex system. 189 2mg Mint Flavored Lozenges + 21 31 mg Patches. OTC that is covered by recall D-1247-2014 from GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
